Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023

SELL
$47.19 - $70.77 $11.3 Million - $17 Million
-240,048 Reduced 99.99%
33 $2,000
Q4 2022

Oct 19, 2023

BUY
$30.35 - $53.15 $7.29 Million - $12.8 Million
240,081 New
240,081 $11.9 Million
Q4 2022

Jan 17, 2023

BUY
$30.35 - $53.15 $607 - $1,063
20 Added 0.01%
240,081 $11.9 Million
Q2 2022

Jul 12, 2022

BUY
$35.61 - $76.23 $1,032 - $2,210
29 Added 0.01%
240,061 $9.46 Million
Q1 2022

Apr 28, 2022

SELL
$57.56 - $82.54 $852,348 - $1.22 Million
-14,808 Reduced 5.81%
240,032 $16.8 Million
Q4 2021

Jan 24, 2022

SELL
$72.5 - $100.68 $5.2 Million - $7.22 Million
-71,758 Reduced 21.97%
254,840 $19.8 Million
Q3 2021

Oct 28, 2021

SELL
$90.24 - $124.05 $6,677 - $9,179
-74 Reduced 0.02%
326,598 $31.2 Million
Q2 2021

Jul 28, 2021

BUY
$93.66 - $139.27 $6.38 Million - $9.49 Million
68,139 Added 26.36%
326,672 $40.6 Million
Q1 2021

May 07, 2021

BUY
$116.57 - $155.01 $1.69 Million - $2.24 Million
14,480 Added 5.93%
258,533 $34.1 Million
Q4 2020

Jan 25, 2021

SELL
$99.61 - $142.12 $255,997 - $365,248
-2,570 Reduced 1.04%
244,053 $32.3 Million
Q3 2020

Oct 30, 2020

SELL
$72.92 - $102.01 $463,187 - $647,967
-6,352 Reduced 2.51%
246,623 $25.2 Million
Q2 2020

Aug 06, 2020

SELL
$55.75 - $92.75 $7.41 Million - $12.3 Million
-132,829 Reduced 34.43%
252,975 $22 Million
Q1 2020

Apr 30, 2020

BUY
$37.9 - $104.44 $150,652 - $415,149
3,975 Added 1.04%
385,804 $22.3 Million
Q4 2019

Jan 21, 2020

SELL
$77.66 - $99.74 $1.69 Million - $2.17 Million
-21,741 Reduced 5.39%
381,829 $35.3 Million
Q3 2019

Oct 21, 2019

SELL
$90.37 - $122.49 $7.83 Million - $10.6 Million
-86,685 Reduced 17.68%
403,570 $36.5 Million
Q2 2019

Jul 09, 2019

SELL
$89.51 - $118.04 $3.93 Million - $5.19 Million
-43,944 Reduced 8.23%
490,255 $57.9 Million
Q1 2019

Apr 10, 2019

SELL
$61.98 - $96.5 $8.35 Million - $13 Million
-134,664 Reduced 20.13%
534,199 $46.3 Million
Q4 2018

Jan 14, 2019

SELL
$56.04 - $82.66 $15.8 Million - $23.3 Million
-281,646 Reduced 29.63%
668,863 $42.2 Million
Q3 2018

Oct 11, 2018

BUY
$48.29 - $80.6 $8.04 Million - $13.4 Million
166,441 Added 21.23%
950,509 $75 Million
Q2 2018

Jul 10, 2018

BUY
$37.84 - $69.96 $29.7 Million - $54.9 Million
784,068 New
784,068 $46.9 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Aegon Asset Management Uk PLC Portfolio

Follow Aegon Asset Management Uk PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aegon Asset Management Uk PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aegon Asset Management Uk PLC with notifications on news.